Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Technology Bridges Gap Between New Genome Data and Years of Research

By LabMedica International staff writers
Posted on 10 Sep 2009
Since the initiation of the Human Genome Project, an explosion of data has sent the science world scurrying. More...
There is a growing demand to customize genomic codes, which inventory the "ingredients for life,” but do not sufficiently clarify how those ingredients function.

A Rutgers University-Camden (NJ, USA) biochemist is addressing this knowledge gap through the creation of a database for quick "background checks” on all known enzyme functions. Because of a U.S. National Institute of Health (Bethesda, MD, USA) grant, Dr. Peter Palenchar, an assistant professor of chemistry at the University of Rutgers-Camden (NJ, USA; ), will categorize decades-worth of research on enzymes into a database, starting with those that bind to molecules that contain adenosine.

The US$200,000 grant will allow Dr. Palenchar to track and simplify what has been written about some 130 enzymes, including energy-creators adenosine triphosphate (ATP) and adenosine diphosphate (ADP). "There are 50-plus years of good data on how enzymes function, but it's a tedious process to understand the specialized language used in enzymology papers. Question is: how do you access that information quickly?” stated Dr. Palenchar. His goal is to create a standard vocabulary to describe how enzymes function for the biomedical community, particularly those who work with anticancer drugs that target enzymes. Dr. Palenchar, with assistance from Rutgers-Camden undergraduate Jason Cargill and graduate student Salvador Gomez, will not only establish this new vocabulary for an accessible database, but also assess its effectiveness in determining the accuracy of genomic codes.

To do this, the Rutgers-Camden research team will compare the genomic sequencing in two organisms that contain "functionally important” amino acids: Arabidopsis thaliana, a plant commonly known as thale cress, and Plasmodium falciparum, the pathogen that causes malaria. "There could be good evidence that these enzymes are doing something different,” noted the biochemist, who has published his research in the past in the journal Genome Biology.

According to Mr. Gomez, who is searching primary publications through online databases such as PubMed and Academic Search Premier, this research is important. "This research has given me an opportunity to do meaningful work at a higher level,” he noted. "Knowing my work will be utilized by other scientists is a great feeling.”

Dr. Palenchar has been studying enzymes for the past 10 years. He teaches biochemistry at Rutgers-Camden.

Related Links:

Rutgers University-Camden



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.